F. GÜRLER Et Al. , "Retrospective Comparison of Chemotherapy Plus Anti-HER2 Therapies at First-line Treatment in Patients with Metastatic Gastric Adenocarcinoma," Dicle Tıp Dergisi , vol.49, no.3, pp.468-476, 2022
GÜRLER, F. Et Al. 2022. Retrospective Comparison of Chemotherapy Plus Anti-HER2 Therapies at First-line Treatment in Patients with Metastatic Gastric Adenocarcinoma. Dicle Tıp Dergisi , vol.49, no.3 , 468-476.
GÜRLER, F., İLHAN GÜLEŞEN, A., & ÇAKMAK ÖKSÜZOĞLU, Ö. B., (2022). Retrospective Comparison of Chemotherapy Plus Anti-HER2 Therapies at First-line Treatment in Patients with Metastatic Gastric Adenocarcinoma. Dicle Tıp Dergisi , vol.49, no.3, 468-476.
GÜRLER, FATİH, AYŞEGÜL İLHAN GÜLEŞEN, And ÖMÜR BERNA ÇAKMAK ÖKSÜZOĞLU. "Retrospective Comparison of Chemotherapy Plus Anti-HER2 Therapies at First-line Treatment in Patients with Metastatic Gastric Adenocarcinoma," Dicle Tıp Dergisi , vol.49, no.3, 468-476, 2022
GÜRLER, FATİH Et Al. "Retrospective Comparison of Chemotherapy Plus Anti-HER2 Therapies at First-line Treatment in Patients with Metastatic Gastric Adenocarcinoma." Dicle Tıp Dergisi , vol.49, no.3, pp.468-476, 2022
GÜRLER, F. İLHAN GÜLEŞEN, A. And ÇAKMAK ÖKSÜZOĞLU, Ö. B. (2022) . "Retrospective Comparison of Chemotherapy Plus Anti-HER2 Therapies at First-line Treatment in Patients with Metastatic Gastric Adenocarcinoma." Dicle Tıp Dergisi , vol.49, no.3, pp.468-476.
@article{article, author={FATİH GÜRLER Et Al. }, title={Retrospective Comparison of Chemotherapy Plus Anti-HER2 Therapies at First-line Treatment in Patients with Metastatic Gastric Adenocarcinoma}, journal={Dicle Tıp Dergisi}, year=2022, pages={468-476} }